Featured Articles

Drug eruptions: approaching the dia...

TABLE 1 Steps in the approach to diagnose a cutaneous adverse reaction Working diagnosis 1-Initial clinical impression...

Lipicard Technologies Study: Platro...

HYDERABAD, India -- All currently available antiplatelet an·ti·plate·let (nt-plt drugs viz- Aspirin, PLA...

The Treatment For Hay Fever

Hay fever does not always require medical treatment. Avoid known or suspected allergens. Hay fever symptoms lend thems...

Ten Warning Signs of Alcoholism Obs...

Alcoholism is a growing problem in the cities among youngsters and people of all age groups This problem has been exis...

New drug protects kids from excess ...

DRUG NEWS

FIND A DRUG

Pharmacy Locator

ZIP Distance

Use this tool to find
pharmacies in your area

Drug Information Related to Leucovorin Calcium

Back

01. Bigmar Reports Second Quarter Results; Sales Increase 8.3 Percent on ....

Business Editors & Health/Medical WritersJOHNSTOWN, Ohio--(BW HealthWire)--Aug. 20, 2001Bigmar, Inc. (OTCBB:BGMR BGMR - Bigmar Inc. (stock symbol)) today reported results for the six-month period ending June 30, 2001.For the six-month period, the company's net sa...

02. FDA Approves Akorn ANDA For Diltiazem HCl Injection; Baxter ...

LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--May 12, 1998-- Akorn and Baxter in Alliance to Develop, Produce and Market Injectables in·ject·a·ble (n-jkt-b Worldwide Akorn, Inc. (NASDAQ:AKRN) announced today that it has received FDA approval of its ANDA app...

03. Bigmar, Inc. Announces Second Quarter Results. - Free Online Library...

COLUMBUS, Ohio--(BUSINESS WIRE)--August 18, 1998--Bigmar, Inc. (Nasdaq:BGMR BGMR - Bigmar Inc. (stock symbol)/Boston Stock Exchange:BGM) today reported financial results for the second quarter ended June 30, 1998 (see attached tables). Net sales for the second ...

04. Bigmar, Inc. Announces 1998 First Quarter Results. - Free Online Libra...

COLUMBUS, Ohio--(BUSINESS WIRE)--May 18, 1998--Bigmar, Inc. (Nasdaq:BGMR BGMR - Bigmar Inc. (stock symbol)/Boston Stock Exchange:BGM) today reported financial results for the first quarter ended March 31, 1998 (see attached tables). In the first quarter of 1998 t...

05. Combination chemotherapy in treating young patients with Langerhans .....

This study is currently recruiting patients. Verified by National Cancer Institute (NCI). Sponsored by United Kingdom Children's Cancer Study Group. This randomized clinical trial is studying combination chemotherapy to see how well it works in treating young patients...

06. Cause for confusion | Nursing | Find Articles at BNET

A hospital reported two medication errors that occurred because of confusion between folinic acid and folic acid. Folinic acid is another name for leucovorin calcium, one of several derivatives of folic acid. Administration of leucovorin calcium can counteract serious t...

07. Folic and folinic acid: Cause for confusion | Nurse Practitioner | Fin...

Two medication errors occurred because of confusion between folinic acid and folic acid. Folinic acid, also known as leucovorin calcium, is a useful antidote to folic acid antagonists. ...

08. Adjuvant therapy for colon and rectal cancer - includes patient ......

Since publication of the original studies documenting a benefit from adjuvant chemotherapy, data from other reports have led to refinements in postoperative management. In a 1992 publication, the GITSG reported that methyl-CCNU was not necessary to obtain beneficial ...

09. Guangzhou Ningkang Synthesis Technology Co., Ltd. China Chemical ......

...

10. Guangzhou Ningkang Synthesis Technology Co., Ltd.(list of drugs and .....

...

11. Guangzhou Ningkang Synthesis Technology Co., Ltd. - Free Online Librar...

Guangzhou Ningkang Synthesis Technology Co., Ltd. Active Pharmaceutical Ingredients No Product CAS No 1 Memantine 41100-52-1 2 Valsartan 137863-60-6 3 Valacyclovir 124832-27-5 4 Famcyclovir 104227...

12. ERBITUX -Cetuximab- Scientific Data in Several Tumor Types Presented a...

ORLANDO, Fla. -- ImClone Systems Incorporated (NASDAQ: IMCL) and Bristol-Myers Squibb Company (NYSE: BMY) today announced the results of several clinical studies of ERBITUX(R) (Cetuximab), an IgG1 monoclonal antibody, presented at the American Society of Clinical Onc...

13. Bigmar files first abbreviated new drug application with FDA for its ....

COLUMBUS, Ohio--(BUSINESS WIRE)--July 1, 1997-- Also Announces Commencement of Shipments to Germany For Commercial Sale of Drug Bigmar, Inc. (Nasdaq SmallCap Market: BGMR BGMR - Bigmar Inc. (stock symbol)/Boston Stock Exchange:BGM) today announced that it has subm...

14. Under treatment: as oncologists struggle with the traditional process ...

Cancer doctors are finding them selves caught between perception and what they say is reality. In the past few months, oncologists have been the target of bad publicity caused by the revenue they receive from the sale of chemotherapy drugs to patients. The doctors ...

15. Bigmar Receives FDA Approval for Daunorubicin Hydrochloride for ......

JOHNSTOWN, Ohio--(BUSINESS WIRE)--June 1, 1999-- BIGMAR, INC. (Nasdaq SmallCap Market: BGMR BGMR - Bigmar Inc. (stock symbol)) today announced that it has received Abbreviated New Drug Application ("ANDA") approval from the Food and Drug Administration ("FDA") for D...